Oral vitamin K effectively treats international normalised ratio (INR) values in excess of 10: Results of a prospective cohort study

Thrombosis and Haemostasis

Volumn 104, Issue 1, 2010, Pages 118-121

  Crowther, Mark A ^a   Garcia, David ^b   Ageno, Walter ^c   Wang, Luqi ^a   Witt, Dan M ^d   Clark, Nathan P ^d   Blostein, Mark D ^e   Kahn, Susan R ^e   Schulman, Sam ^a   Kovacs, Michael ^f   Rodger, Marc A ^g   Wells, Philip ^g   Anderson, David ^h   Ginsberg, Jeffrey ^a   Selby, Rita ⁱ   Siragusa, Sergio ^j   Silingardi, Mauro ^h   Dowd, MaryBeth B ^d   Kearon, Clive ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY OF NEW MEXICO   (United States)

^c UNIVERSITY OF INSUBRIA   (Italy)

^d Clinical Pharmacy Anticoagulation Service   (United States)

^e MCGILL UNIVERSITY   (Canada)

^f UNIVERSITY OF WESTERN ONTARIO   (Canada)

^g UNIVERSITY OF OTTAWA   (Canada)

^h Department of Medicine ^*  (Italy)

ⁱ UNIVERSITY OF TORONTO   (Canada)

^j UNIVERSITY OF PALERMO   (Italy)

more..

Author keywords

Acquired coagulation disorders; Haemostasis; Oral anticoagulants; Thrombosis

Indexed keywords

VITAMIN K GROUP; WARFARIN;

AGED; ARTICLE; BLEEDING; CLINICAL TRIAL; COHORT ANALYSIS; DRUG SAFETY; FEMALE; HEMOSTASIS; HUMAN; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SINGLE DRUG DOSE; THROMBOEMBOLISM;

ADMINISTRATION, ORAL; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; FEMALE; FOLLOW-UP STUDIES; HEMORRHAGE; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; VENOUS THROMBOSIS; VITAMIN K; WARFARIN;

EID: 77954360557     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH09-12-0822     Document Type: Article

References (14)

1. Oden A, Fahlen M. Oral anticoagulation and risk of death: a medical record link-age study. Br Med J 2002; 325: 1073-1075. (Pubitemid 35351801)
2. Ansell J, Hirsh J, Poller L, et al. The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126 (3 Suppl): 204S-233S.
3. Palareti G, Leali N, Coccheri S, et al. Bleeding complications of oral anticoagulant treatment: an inception- cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy. Lancet 1996; 348: 423-428.
4. Palareti G, Cosmi B. Bleeding with anticoagulation therapy - who is at risk, and how best to identify such patients. Thromb Haemost 2009; 102: 268-278.
5. Baker P, Gleghorn A, Tripp T, et al. Reversal of asymptomatic over-anticoagulation by orally administered vitamin K. Br J Hematol 2006; 133: 331-336.
6. Dezee KJ, Shimeall WT, Douglas KM, et al. Treatment of excessive anticoagulation with phytonadione (vitamin K): a meta-analysis. Arch Intern Med 2006; 166: 391-397. (Pubitemid 43313641)
7. Gunther KE, Conway G, Leibach L, et al. Low-dose oral vitamin K is safe and effective for outpatient management of patients with an INR>10. Thromb Res 2004; 113: 205-209.
8. Lubetsky A, Shasha Y, Olchovsky D, et al. Impact of pre-treatment INR level on the effect of intravenous low dose vitamin K in patients with excessive anticoagulation. Thromb Haemost 2003; 90: 71-76. (Pubitemid 36873861)
9. Dentali F, Ageno W, Crowther M. Treatment of coumarin-associated coagulopathy: a systematic review and proposed treatment algorithms. J Thromb Haemost 2006; 4: 1853-1863. (Pubitemid 44226758)
10. Denas G, Cucchini U, Iliceto S, et al. An oral vitamin K protocol to reverse over-anticoagulation in patients presenting with an International Normalised Ratio above 10.0. Thromb Haemost 2009; 101: 410-411.
11. Crowther M, Ageno W, Garcia D, et al. Vitamin K versus placebo in the correction of overanticoagulated patients receiving warfarin. A randomized trial. Ann Intern Med 2009; 150: 293-300.
12. Beinema M, Brouwers JR, Schalekamp T, et al. Pharmacogenetic differences between warfarin, acenocoumarol and phenprocoumon. Thromb Haemost 2008; 100: 1052-1057.
13. Ageno W, Crowther M, Steidl L, et al. Low dose oral vitamin K to reverse acenocoumarol-induced coagulopathy: a randomized controlled trial. Thromb Haemost 2002; 88: 48-51. (Pubitemid 34759875)
14. Penning-van Beest FJ, Rosendaal FR, Grobbee DE, et al. Course of the international Normalized Ratio in response to oral vitamin K1 in patients overanticoagulated with phenprocoumon. Br J Haematol 1999; 104: 241-245.